In a mouse model for tauopathy, Litvinchuk et al. [22] have shown that a synthetic LXR agonist, GW3965, increases gene expression of ABCA1, which is the major cholesterol efflux protein that controls cellular cholesterol disposal [23]. Here, ABCA1 is linked to tauopathy.